A Vision to be the Best
As the largest group of Retina specialists in the Greater Kansas City, Topeka, Sedalia and surrounding areas we offer multiple professional offices to serve you. Each of our offices are staffed and equipped to provide the highest level of health care service and access in a comfortable environment.
Retina Associates
Research-at the forefront of care
Retina Associates has a team of researchers that are focused on advancing and improving the treatment of diseases of the retina, macula and vitreous through clinical studies, teaching, and development of new instruments and techniques. Our physician’s have participated in a multitude of research studies and in many our physicians have served as principal investigators or co-investigators. Current studies that we are involved in are:
Enrolled Studies
1. DRCR: Protocol T - A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
2. Allergan: BDP 1 A 12-Month, Multicenter, 2-Stage (Open Label, Dose-Escalation, followed by masked, Randomized) Single Dose Study of the Safety and Efficacy of AGN-208397 in patients with Macular Edema (ME) Associated with Retinal Vein Occlusion (RVO)
3. MERCK: EPOCH - A Randomized, Placebo Controlled, Parallel-Group, Double Blind Efficacy and Safety Trial of MK-8931 in Subjects with Mild to Moderate Alzheimer's Disease. (We are conducting the ophthalmology portion of this study for KU Medical Center)
We have a few more upcoming studies with start-up dates in late spring. More information will be published as it becomes available.
